These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 29848678)

  • 1. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
    Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
    Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer.
    Tsai KW; Leung CM; Lo YH; Chen TW; Chan WC; Yu SY; Tu YT; Lam HC; Li SC; Ger LP; Liu WS; Chang HT
    Sci Rep; 2016 Jun; 6():28176. PubMed ID: 27307030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
    Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q
    PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
    Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
    Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells.
    Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC
    Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
    Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.
    Pu Y; Zhao F; Cai W; Meng X; Li Y; Cai S
    Clin Exp Metastasis; 2016 Apr; 33(4):359-72. PubMed ID: 26913720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis.
    Ma P; Wang H; Sun J; Liu H; Zheng C; Zhou X; Lu Z
    Cell Cycle; 2018; 17(8):974-984. PubMed ID: 29895195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-associated silencing of
    Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1.
    Jiang D; Li H; Xiang H; Gao M; Yin C; Wang H; Sun Y; Xiong M
    Med Sci Monit; 2019 Feb; 25():1537-1548. PubMed ID: 30810117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway.
    Takao K; Konishi H; Matsubara D; Shoda K; Arita T; Shimizu H; Komatsu S; Shiozaki A; Yamamoto Y; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Anticancer Res; 2021 May; 41(5):2441-2449. PubMed ID: 33952469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00152 down-regulated
    Huang Y; Luo H; Li F; Yang Y; Ou G; Ye X; Li N
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29339419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
    Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
    Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6.
    Li Q; Wang N; Wei H; Li C; Wu J; Yang G
    Dig Dis Sci; 2016 Dec; 61(12):3486-3497. PubMed ID: 27743162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistency analysis of microRNA-arm expression reveals microRNA-369-5p/3p as tumor suppressors in gastric cancer.
    Dong L; Zhang Z; Xu J; Wang F; Ma Y; Li F; Shen C; Liu Z; Zhang J; Liu C; Yi P; Yu J
    Mol Oncol; 2019 Jul; 13(7):1605-1620. PubMed ID: 31162777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1.
    Liu Y; Xu X; Xu X; Li S; Liang Z; Hu Z; Wu J; Zhu Y; Jin X; Wang X; Lin Y; Chen H; Mao Y; Luo J; Zheng X; Xie L
    Oncol Lett; 2017 Nov; 14(5):5121-5128. PubMed ID: 29142597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.